Following the internalization of nanocarriers into the target cells, it is necessary to release the payload precisely to their subcellular sites of action, like mitochondria, lysosomes, and nuclei [76,77,78]
One compound that has garnered significant clinical interest is Acetyl-L-Carnitine (ALCAR)
These findings suggest retatrutide may have potential as a treatment for both diabetes and obesity, though larger trials are needed to confirm these effects
Two symbols (**, ##, or $$) denote significant difference below 0.005, three symbols (***, ###, or $$$) denote significant below 0.0001
If you miss your daily injection and remember within 12 hours, take it immediately
Several studies are underway to test adjunctive therapies in type 1 diabetes and may help move the needle towards approvals